Member of the board since 2019
Fredrik Lehmann has a PhD in pharmaceutical chemistry and has over 15 years of experience in drug development. Previously, he has worked at Pharmacia, Biovitrum, OT Chemistry and Recipharm, and has founded and operated six companies within Life Science.
M.Sc in Chemistry Uppsala universitet, PhD in Pharmaceutical chemistry Göteborgs Universitet
Head of reseach Oncopeptides, Chairman of the Board Synartro AB, Member of the Board Immuneed, Independent consultant within CMC
Number of shares (As of May 11th, 2022)
Fredrik is independent in relation to the Company and its senior executives as well as independent
in relation to major shareholders.